Nuzenio

Grace Therapeutics Says

Grace Therapeutics Says news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 15 latest news signals 9 publisher sources 100/100 entity strength

Latest news

Grace Therapeutics (GRCE): Opaleye reports 2.75M-share, 13.07% ownership stake - Stock TitanStock Titan · Fri, 07 Aug 2026 20:06:08 GMTGrace Therapeutics, Inc. Revenue Breakdown – NASDAQ:GRCE - TradingViewTradingView · Fri, 07 Aug 2026 12:57:52 GMTGRCE Stock Plunges 45% After FDA Rejects Brain Injury Drug — Company Says Concerns Are Fixable - StocktwitsStocktwits · Fri, 07 Aug 2026 08:05:22 GMTGrace Therapeutics Raises $10 Million in Private Placement, Grants Registration Rights - TradingViewTradingView · Thu, 06 Aug 2026 20:13:22 GMTGrace Therapeutics announces securities purchase agreement for $10M private placement - ROI-NJROI-NJ · Thu, 06 Aug 2026 14:12:11 GMTGrace Therapeutics raises USD 10m to fund dual manufacturing strategy for GTx-104 NDA resubmission - AllSciAllSci · Wed, 05 Aug 2026 11:40:39 GMTGrace Therapeutics Secures $10M Private Placement Agreement - Intellectia AIIntellectia AI · Wed, 05 Aug 2026 07:51:33 GMTGrace Therapeutics Expects Funding to Extend Cash Runway Through 2028 - Stock TitanStock Titan · Wed, 05 Aug 2026 03:43:14 GMT

Timeline

Fri, 07 Aug 2026 20:06:08 GMTGrace Therapeutics (GRCE): Opaleye reports 2.75M-share, 13.07% ownership stake - Stock Titan
Fri, 07 Aug 2026 12:57:52 GMTGrace Therapeutics, Inc. Revenue Breakdown – NASDAQ:GRCE - TradingView
Fri, 07 Aug 2026 08:05:22 GMTGRCE Stock Plunges 45% After FDA Rejects Brain Injury Drug — Company Says Concerns Are Fixable - Stocktwits
Thu, 06 Aug 2026 20:13:22 GMTGrace Therapeutics Raises $10 Million in Private Placement, Grants Registration Rights - TradingView
Thu, 06 Aug 2026 14:12:11 GMTGrace Therapeutics announces securities purchase agreement for $10M private placement - ROI-NJ
Wed, 05 Aug 2026 11:40:39 GMTGrace Therapeutics raises USD 10m to fund dual manufacturing strategy for GTx-104 NDA resubmission - AllSci

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Grace Therapeutics Says.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

9 distinct publisher/source names are currently connected to this entity page.